# CCR5 Inhibitor Treatment Intensification on CD4+ T-cell Recovery

> **NCT00925756** · PHASE4 · COMPLETED · sponsor: **University of California, San Diego** · enrollment: 32 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Maraviroc

## Key facts

- **NCT ID:** NCT00925756
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10-20
- **Primary completion:** 2012-05-02
- **Final completion:** 2014-04-11
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2020-08-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00925756

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00925756, "CCR5 Inhibitor Treatment Intensification on CD4+ T-cell Recovery". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00925756. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*